Lilly joins with Chinese biotech to develop, market cancer drugs
March 19, 2015 at 22:56 PM EDT
Eli Lilly agrees to form one of the broadest collaborations to date between a large Western drug maker and a Chinese biotechnology company, a sign of the pharmaceutical industry’s interest in the Chinese market despite recent growing pains.